Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-27

Clinical Trial Update: Nalmefene in Alcohol Dependence and Borderline Personality Disorder [NA]

View source ↗

Summary

Nalmefene is being studied for Alcohol Use Disorder and Borderline Personality Disorder, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalmefene (nalmefene)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Alcohol Use Disorder, Borderline Personality Disorder | NA | Status: UNKNOWN